BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ground Zero Pharmaceuticals Announces Opening of Additional Office in Brisbane, Australia


10/6/2009 6:43:46 AM

Bookmark and Share

IRVINE, Calif., Oct. 6 /PRNewswire/ -- A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration. Our new office in downtown Brisbane, Australia was established on July 1 and we are adding Australia-based associates with FDA, TGA and EMEA experience to expand access to our worldwide expertise in regulatory-based medical product development and increase our local client's ability to meet conveniently with our staff .

Current activities in Australia include speaking engagements for Dr. Evan Siegel at the following venues in October:

21/10/2009 - Adelaide - 2009 National Preclinical Seminar Series - "Getting to the IND"

28/10/2009 - Melbourne - AusBiotech 2009 - "Global Regulatory Challenges and Opportunities"

Internationally, GZP continues to believe that early and frequent communication with the FDA as the key regulatory agency can lead to accelerated product development, better use of resources, and more funding.

In 2009, despite a difficult climate, GZP increased the number of US, Australian, and European clients with US FDA programs both early and late in development in the indications of oncology, infectious disease, cardiovascular medicine, neurological disease and immune function disorders.

INDs created and submitted in 2008/2009 received first-cycle clearance to proceed with clinical trials. Pre-pre-IND, pre-IND and mid-phase meetings with the FDA led to rapid movement of drug and biologic development programs for our clients.

According to Evan Siegel, "We continue to benefit from the loyalty of our clients, their referrals, and expansion into new regions, by continuing to uphold our core principles of exceptional quality staff, generation of creative, high-value deliverables, and enhanced strategic planning."

In related developments, GZP has augmented its staff in the Regulatory, Nonclinical, and biologics Chemistry, Manufacturing and Controls areas to further serve its clients.

Based in Irvine, a major biotechnology center in Southern California, Ground Zero Pharmaceuticals, Inc. is a regulatory affairs and product development consulting firm providing strategic and tactical support to the pharmaceutical, biotechnology and medical device industries. Its services include regulatory representation and submissions (paper and electronic), strategic medical consulting, preclinical planning, auditing and review of clinical, nonclinical and CMO sites, medical writing, chemistry, manufacturing and controls consulting, clinical assessment, data management, biostatics, and project management. GZP has strategic resources, throughout the US, Canada, Australia and Europe, and a wholly owned subsidiary in Brisbane and Melbourne, Australia.

For further information please contact Ms. Tisha Templeton, Senior Vice President of Finance and Operations, Ground Zero Pharmaceuticals, Inc., +1-949-852-3666, fax, +1-949-852-3655,

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES